EGHRIN has published and is planning to publish a series of position papers with regards the European Commission’s proposals for Horizon Europe, the next EU Research Framework Programme. The intent of EGHRIN is to include Global Health Research in a more comprehensive way in order to further strengthen the impact of Horizon Europe.

EGHRIN’s suggestions on the legislative framework of Horizon Europe

EGHRIN has published a paper with suggestions to make the legal frame work of of Horizon Europe more inclusive on global health. This technical document provides suggestions how to improve the legal text underlying Horizon Europe to facilitate this process.

Download PDF file

EGHRIN’s position paper on the strategic planning process of  Horizon Europe

EGHRIN has published a paper, in which we respond to the Health “Cluster” within the Commission’s proposal for Horizon Europe. This paper provides detailed suggestions on how strategic investments and considerations regarding partnerships and investment instruments will support research and innovations for poverty related and neglected infectious diseases.

Such investments will save lives, will help to combat ongoing epidemics, can prevent future catastrophic outbreaks, and will have a great economic return on investment for Europe, while creating quality jobs and driving scientific excellence.

Download PDF file

EGHRIN’s suggestions for a new Global Health partnership: EDCTP3

EGHRIN and its members find it essential to have a dedicated mechanism for funding Global Health research within Horizon Europe. Currently, EDCTP2 is the only dedicated mechanism for Global Health research of poverty-related infectious diseases within Horizon 2020. 

EDCTP3 can be fully equipped to promote the development and uptake of new products for poverty related diseases. 

Download PDF file

Global health research and innovation should be priority for Horizon Europe: Lancet commentary

Investing in global health and innovation should be higher priority in Europe’s new research funding program, according to a newly published Lancet commentary.

The piece was developed by members of the European Global Health Research Institutes Network (EGHRIN), whose membership includes research institutes and universities affiliated with global health institutes in Europe. The network, co-launched by AIGHD, seeks to develop a global health research agenda for Europe and advocate for a higher profile of global health within the new EU research funding program Horizon Europe.

The European Commission recently published its proposal for Horizon Europe, a €100 billion research and innovation programme that will succeed Horizon 2020.

“Ensuring global health is part of this new funding program is more important than it ever was and deserves a clearly recognizable place in the program,” said prof. Frank Cobelens, AIGHD academic staff and lead author, adding the amount of money allocated to the health cluster within Horizon Europe’s proposed budget is less than what was allocated as part of Horizon 2020.

Frank Cobelens

“Strengthening the commitment to global health as part of the program will have a number of benefits including strengthening European science and providing an opportunity to innovate in the development of products and services and involve European providers, to name a few.”

Read the full commentary on The Lancet website.

Publication of EGHRIN authors in British Medical Journal: Where is the ‘global’ in the European Union’s Health Research and Innovation Agenda ?

In this publication in BMJ, EGHRIN scientists publish an analysis that takes the evolvement of Horizon Europe from the initial framework of June 2018 to the framework agreed on in April 2019 into account. Their analysis shows that despite some improvements in terms of Global Health and reference to the Sustainable Development Goals, European industrial competitiveness continues to play a paramount role, with Global Health research needs and relevant health research for LMICs being only partially addressed. They argue that the globally interconnected nature of health and the transdisciplinary nature of health research need to be fully taken into account and acted on in the new European Research and Innovation Framework.

Astrid Berner-Rodoreda

Read the full article with Astrid Berner-Rodoreda from the Heidelberg Institute of Global Health (HIGH), Germany as lead author on the BMJ website